Literature DB >> 21071980

Expression of Transcription Factor GATA-6 in Alveolar Epithelial Cells Is Linked to Neonatal Lung Disease.

Riika Vähätalo1, Tiina M Asikainen, Riitta Karikoski, Vuokko L Kinnula, Carl W White, Sture Andersson, Markku Heikinheimo, Marjukka Myllärniemi.   

Abstract

BACKGROUND: Premature birth and respiratory distress syndrome (RDS) are risk factors for disturbed lung development and bronchopulmonary dysplasia (BPD). The molecular mechanisms related to prematurity and BPD remain largely unknown. Epithelial expression of the transcription factor GATA-6 has been implicated in normal and abnormal murine lung development.
OBJECTIVES: The possible involvement of GATA-6 in the normal development and in RDS and BPD was investigated in the human and baboon lung.
METHODS: Immunohistochemistry was used to study the expression of GATA-6 and thyroid transcription factor 1 in lung specimens from different age groups of human and baboon fetuses and newborns with lung disease. Furthermore, the regulatory role of TGF-β₁ in GATA-6 expression was investigated in human pulmonary epithelial cell lines using RT-PCR.
RESULTS: GATA-6 expression increased in the developing human airway epithelium along with advancing gestation, but diminished to negligible at birth. In RDS, GATA-6 expression was enhanced at 5-7 days after birth, and decreased thereafter. In BPD, the expression of GATA-6 in alveolar epithelial cells was low. These results were confirmed and extended using an established baboon model of prematurity. The in vitro experiments revealed that TGF-β₁ induces GATA-6 and thyroid transcription factor 1 expression in lung epithelial cells.
CONCLUSIONS: Our results suggest that the expression of GATA-6 at the early stages of the preterm lung may be related to impaired postnatal alveolar development.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21071980      PMCID: PMC2992637          DOI: 10.1159/000317827

Source DB:  PubMed          Journal:  Neonatology        ISSN: 1661-7800            Impact factor:   4.035


  36 in total

Review 1.  The new BPD: an arrest of lung development.

Authors:  A J Jobe
Journal:  Pediatr Res       Date:  1999-12       Impact factor: 3.756

Review 2.  Inflammation and bronchopulmonary dysplasia: a continuing story.

Authors:  Christian P Speer
Journal:  Semin Fetal Neonatal Med       Date:  2006-05-15       Impact factor: 3.926

Review 3.  Role of the GATA family of transcription factors in endocrine development, function, and disease.

Authors:  Robert S Viger; Séverine Mazaud Guittot; Mikko Anttonen; David B Wilson; Markku Heikinheimo
Journal:  Mol Endocrinol       Date:  2008-01-03

Review 4.  Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease.

Authors:  Bernard Thébaud; Steven H Abman
Journal:  Am J Respir Crit Care Med       Date:  2007-02-01       Impact factor: 21.405

5.  Impaired mesenchymal cell function in Gata4 mutant mice leads to diaphragmatic hernias and primary lung defects.

Authors:  Patrick Y Jay; Malgorzata Bielinska; Jonathan M Erlich; Susanna Mannisto; William T Pu; Markku Heikinheimo; David B Wilson
Journal:  Dev Biol       Date:  2006-10-05       Impact factor: 3.582

6.  Gata4 is necessary for normal pulmonary lobar development.

Authors:  Kate G Ackerman; Jianlong Wang; Liqing Luo; Yuko Fujiwara; Stuart H Orkin; David R Beier
Journal:  Am J Respir Cell Mol Biol       Date:  2006-12-01       Impact factor: 6.914

7.  TGF-beta-neutralizing antibodies improve pulmonary alveologenesis and vasculogenesis in the injured newborn lung.

Authors:  Hidehiko Nakanishi; Takahiro Sugiura; James B Streisand; Scott M Lonning; Jesse D Roberts
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-03-30       Impact factor: 5.464

8.  Transcription factor GATA-6 is expressed in quiescent myofibroblasts in idiopathic pulmonary fibrosis.

Authors:  Outi Leppäranta; Ville Pulkkinen; Katri Koli; Riika Vähätalo; Kaisa Salmenkivi; Vuokko L Kinnula; Markku Heikinheimo; Marjukka Myllärniemi
Journal:  Am J Respir Cell Mol Biol       Date:  2009-07-13       Impact factor: 6.914

9.  Hyperoxia modulates TGF-beta/BMP signaling in a mouse model of bronchopulmonary dysplasia.

Authors:  Miguel A Alejandre-Alcázar; Grazyna Kwapiszewska; Irwin Reiss; Oana V Amarie; Leigh M Marsh; Julia Sevilla-Pérez; Malgorzata Wygrecka; Bastian Eul; Silke Köbrich; Mareike Hesse; Ralph T Schermuly; Werner Seeger; Oliver Eickelberg; Rory E Morty
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-10-27       Impact factor: 5.464

Review 10.  Transforming growth factor-beta activation in the lung: focus on fibrosis and reactive oxygen species.

Authors:  Katri Koli; Marjukka Myllärniemi; Jorma Keski-Oja; Vuokko L Kinnula
Journal:  Antioxid Redox Signal       Date:  2008-02       Impact factor: 8.401

View more
  3 in total

1.  Silencing of GATA6 suppresses SW1990 pancreatic cancer cell growth in vitro and up-regulates reactive oxygen species.

Authors:  Wen-Bo Chen; Feng-Ting Huang; Yan-Yan Zhuang; Jian Tang; Xiao-Hong Zhuang; Wen-Jie Cheng; Zhi-Qiang Gu; Shi-Neng Zhang
Journal:  Dig Dis Sci       Date:  2013-07-06       Impact factor: 3.199

2.  Loss of cilia causes embryonic lung hypoplasia, liver fibrosis, and cholestasis in the talpid3 ciliopathy mutant.

Authors:  Megan G Davey; Lynn McTeir; Andrew M Barrie; Lucy J Freem; Louise A Stephen
Journal:  Organogenesis       Date:  2014-04-17       Impact factor: 2.500

3.  Novel and functional DNA sequence variants within the GATA6 gene promoter in ventricular septal defects.

Authors:  Chunyu Li; Xianke Li; Shuchao Pang; Wei Chen; Xianyun Qin; Wenhui Huang; Changqing Zeng; Bo Yan
Journal:  Int J Mol Sci       Date:  2014-07-17       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.